PMID- 21514443 OWN - NLM STAT- MEDLINE DCOM- 20110826 LR - 20211020 IS - 1525-2191 (Electronic) IS - 0002-9440 (Print) IS - 0002-9440 (Linking) VI - 178 IP - 5 DP - 2011 May TI - Lack of TNF-alpha-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. PG - 2311-21 LID - 10.1016/j.ajpath.2011.01.045 [doi] AB - Homotypic cell fusion occurs in several cell types including macrophages in the formation of foreign body giant cells. Previously, monocyte chemoattractant protein-1 (MCP-1) was demonstrated to be required for foreign body giant cell formation in the foreign body response. The present study investigated the fusion defect in MCP-1-null macrophages by implanting biomaterials intraperitoneally in wild-type and MCP-1-null mice and monitoring the macrophage response at 12 hours to 4 weeks. MCP-1-null mice exhibited reduced accumulation and fusion of macrophages on implants, which was associated with attenuation of the foreign body response. Consistent with previous in vitro findings, the level of matrix metalloproteinase-9 (MMP-9) was reduced in MCP-1-null macrophages adherent to implants. In contrast, CCR2 expression was unaffected. In vitro studies revealed reduced tumor necrosis factor-alpha (TNF-alpha) production and abnormal subcellular redistribution of E-cadherin and beta-catenin during fusion in MCP-1-null macrophages. Exogenous TNF-alpha caused an increase in the production of MMP-9 and rescued the fusion defect. Addition of GM6001 (MMP inhibitor) or NSC23766 (Rac1 inhibitor) indicated two distinct induction pathways, one for E-cadherin/beta-catenin and one for MCP-1, TNF-alpha, and MMP-9. Considered together, these observations demonstrate that induction of E-cadherin/beta-catenin is not sufficient for fusion in the absence of MCP-1 or the downstream mediators TNF-alpha and MMP-9. Moreover, attenuation of the foreign body response in intraperitoneal implants in MCP-1-null mice demonstrates that the process depends on tissue-specific factors. CI - Copyright (c) 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. FAU - Skokos, Eleni A AU - Skokos EA AD - Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. FAU - Charokopos, Antonios AU - Charokopos A FAU - Khan, Khadija AU - Khan K FAU - Wanjala, Jackie AU - Wanjala J FAU - Kyriakides, Themis R AU - Kyriakides TR LA - eng GR - R01 GM072194/GM/NIGMS NIH HHS/United States GR - GM072194-01/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (Cadherins) RN - 0 (Ccl2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Blotting, Western MH - Cadherins/*metabolism MH - Cell Adhesion/physiology MH - Chemokine CCL2/*metabolism MH - Chemotaxis, Leukocyte/physiology MH - Enzyme-Linked Immunosorbent Assay MH - Giant Cells, Foreign-Body/*metabolism MH - Immunohistochemistry MH - Macrophages/metabolism MH - Matrix Metalloproteinase 9/*metabolism MH - Mice MH - Mice, Knockout MH - Microscopy, Electron, Transmission MH - Polymerase Chain Reaction MH - Tumor Necrosis Factor-alpha/*metabolism PMC - PMC3081180 EDAT- 2011/04/26 06:00 MHDA- 2011/08/30 06:00 PMCR- 2012/05/01 CRDT- 2011/04/26 06:00 PHST- 2010/08/06 00:00 [received] PHST- 2010/12/15 00:00 [revised] PHST- 2011/01/18 00:00 [accepted] PHST- 2011/04/26 06:00 [entrez] PHST- 2011/04/26 06:00 [pubmed] PHST- 2011/08/30 06:00 [medline] PHST- 2012/05/01 00:00 [pmc-release] AID - S0002-9440(11)00161-1 [pii] AID - AJPA272 [pii] AID - 10.1016/j.ajpath.2011.01.045 [doi] PST - ppublish SO - Am J Pathol. 2011 May;178(5):2311-21. doi: 10.1016/j.ajpath.2011.01.045.